137 / 1084
Neoscope Study – What Can We Conclude?
CarPacRT
passed the pre-specified efficacy criteria for taking forward
to phase III trial.
OxCapRT
failed to meet the same criteria
CarPacRT
can be taken forward to phase III.
© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick